<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Lc3_Autophagy_Wiki</id>
		<title>Lc3 Autophagy Wiki - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Lc3_Autophagy_Wiki"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Lc3_Autophagy_Wiki&amp;action=history"/>
		<updated>2026-04-19T08:42:23Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Lc3_Autophagy_Wiki&amp;diff=180383&amp;oldid=prev</id>
		<title>Rifleeel4: Створена сторінка: 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. emission computed tomography/computed tomography. Mol Imaging Biol. 8: 32432. Mouzon A, Kerger J, D'Hondt L,...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Lc3_Autophagy_Wiki&amp;diff=180383&amp;oldid=prev"/>
				<updated>2017-05-24T11:31:55Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. emission computed tomography/computed tomography. Mol Imaging Biol. 8: 32432. Mouzon A, Kerger J, D&amp;#039;Hondt L,...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. emission computed tomography/computed tomography. Mol Imaging Biol. 8: 32432. Mouzon A, Kerger J, D'Hondt L, Spinewine A Possible Interactions with Anticancer Agents: A Cross-Sectional Study. Chemotherapy. 59: 8592. Kudawara I, Aoki Y, Ueda T, Araki N, Naka N, et al. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma on the extremities: a phase II trial in Japan. J Chemother.; 25: 418. Lillehei KO, Kong Q, Withrow SJ, Kleinschmdt-DeMasters B Efficacy of intralesionally administered cisplatin-impregnated biodegradable polymer for the treatnment of 9L gliosarcoma in the rat. Neurosurgery. 39: 11917. Dhanikula RS, Argaw A, Bouchard JF, Hildgren P Methotrexate loaded polyether-copolyester dendrimers for the remedy of gliomas: enhanced efficacy and intratumoral transport capability. Mol Pharm. 5: 10516. Minami T, Okazaki J, Kawabata A, Kuroda R, Okazaki Y Penetration of cisplatin into mouse brain by lipopolysaccharide. Toxicology. 130: 10713. Angelov L, Doolittle ND, Kraemer DF, Siegal T, Barnett GH, et al. Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for  newly diagnosed primary CNS lymphoma: a multi-institutional experience. J Clin Oncol. 27: 35039. Banks WA, Owen JB, Erickson MA Insulin in the brain: there and back once more. Pharmacol Ther. 136: 8293. Marquet F, Tung YS, Teichert T, Ferrera VP, Konofagou EE Noninvasive, transient and selective blood-brain barrier opening in non-human primates in vivo. PLoS One particular; six: e22598. Blanchette M, Fortin D Blood-brain barrier disruption within the remedy of brain tumors. Procedures Mol Biol. 686: 44763. Cosolo WC, Martinello P, Louis WJ, Christophidis N Blood-brain barrier disruption using mannitol: time course and electron microscopy studies. Am J Physiol. 256: R4437. Deng CX Targeted drug delivery across the blood-brain barrier using ultrasound strategy.Ther Deliv. 1: 819848 Mesiwala AH, Farrell L, Wenzel HJ, Silbergeld DL, Crum LA, et al. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med Biol. 28: 389400. Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K Cellular mechanisms in the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol. 30: 97989. Hynynen K, McDannold N, Vykhodtseva N, Raymond S, Weissleder R, et al. Focal disruption with the blood-brain barrier on account of 260-kHz ultrasound bursts: a technique for molecular imaging and targeted drug delivery. J Neurosurg. 105: 44554. 37. Waterhouse RN Determination of lipophilicity and its use as a predictor of bloodbrainbarrier penetration of molecular imaging agents.  Mol Imaging Biol. five: 37689. 38. Greig NH, Daly EM, Sweeney DJ, Rapoport SI Pharmacokinetics of chlorambuciltertiarybutyl ester, a lipophilic chlorambucil derivative that achieves and maintains highconcentrations in brain. Cancer Chemother Pharmacol.; 25: 3205. 39. Carman AJ, Mills JH, Krenz A, Kim DG, Bynoe MS Adenosine receptor signaling modulates permeability of the blood-brain barrier.J Neurosci.; 31: 1327280. 40. Stopa B, Rybarska J, Drozd A, Konieczny L, Krol M, et al. Albumin binds self-assembling dyes as certain [http://www.medchemexpress.com/Tipifarnib.html 192185-72-1] polymolecular ligands. Int J Biol Macromol. 40: 18. 41 BJ, et al. In vivo  quantitation of intratumoral radioisotope uptake applying micro-single photon 9 Delivery of `Small' Molecules to the Brain 23. 24. 25.&lt;/div&gt;</summary>
		<author><name>Rifleeel4</name></author>	</entry>

	</feed>